| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Virology, Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane Road, London, United Kingdom, W12 0NN [L. G. L. B. E. G.], and Imperial Cancer Research Fund Clinical Oncology Unit, Guy's Hospital, London, United Kingdom SE1 9RT [D. M. B., I. S. F.]
The human herpes virus Epstein-Barr (EBV) is clearly associated with African Burkitt's lymphoma and the undifferentiated form of nasopharyngeal carcinoma, although its role in oncogenesis is still poorly defined. Recently EBV has been implicated in other types of lymphomas, as well as in some nonlymphomatous neoplastic processes. Its possible association with human breast cancer has been investigated here. DNA from 91 cases of breast carcinoma and blood samples from the same patients were amplified with the PCR over a region in the EBV BamHIW major repeat sequence following a single-step amplification protocol. Nineteen samples (21%) were found to be positive; 10 samples of blood (only 3 of them from patients with EBV-positive tumors) were found by the adopted protocol to contain EBV DNA. Another series of PCR amplifications using primers covering a unique (nonreiterated) fragment in BamHIC encoding the EBERs (two short nonpolyadenylated RNAs generally highly expressed in cells latently infected with EBV) confirmed these findings. A good correlation between the two sets of experiments was observed, and only five differences in results were obtained on samples tested. In situ hybridization was carried out using BamHIW biotinylated DNA probes or EBER-1 digoxigenin-labeled riboprobes with the aim of confirming as well as localizing the signal to the epithelial cell. Twelve sections (63%) among the PCR-positive samples were found positive by in situ hybridization with the DNA probe, and six (31.5%) sections were found with the RNA probe. Twenty-one samples from benign breast tumors or normal breast tissue were used as controls for PCR amplification in this study, none of which was found positive. This is the first known report showing positive results for EBV in breast cancer. No statistical association was found in these studies between the presence of EBV and the histological type of the tumor, however. Its role therefore remains for the moment unknown, as well as does the significance of the association of EBV with only a subset of the cases.
1 This study is supported in part by a Grant from the Medical Research Council of Canada and Hammersmith and Queen Charlotte's Special Health Authority (L. G. L.), by the Imperial Cancer Research Fund (I. S. F., D. M. B.), and by the Cancer Research Campaign (B. E. G.).
2 To whom requests for reprints should be addressed.
Received 7/ 5/94. Accepted 11/15/94.
This article has been cited by other articles:
|
|
 |
|
  H-J Delecluse, R Feederle, B O'Sullivan, and P Taniere Epstein Barr virus-associated tumours: an update for the attention of the working pathologist J. Clin. Pathol., December 1, 2007; 60(12): 1358 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Lin, C.-H. Tsai, J.-S. Chu, J.-Y. Chen, K. Takada, and J.-Y. Shew Dysregulation of HER2/HER3 Signaling Axis in Epstein-Barr Virus-Infected Breast Carcinoma Cells J. Virol., June 1, 2007; 81(11): 5705 - 5713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Arbach, V. Viglasky, F. Lefeu, J.-M. Guinebretiere, V. Ramirez, N. Bride, N. Boualaga, T. Bauchet, J.-P. Peyrat, M.-C. Mathieu, et al. Epstein-Barr Virus (EBV) Genome and Expression in Breast Cancer Tissue: Effect of EBV Infection of Breast Cancer Cells on Resistance to Paclitaxel (Taxol) J. Virol., January 15, 2006; 80(2): 845 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Perrigoue, J. A. den Boon, A. Friedl, M. A. Newton, P. Ahlquist, and B. Sugden Lack of Association between EBV and Breast Carcinoma Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 809 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, S.-A. Xue, G. Hallden, J. Francis, M. Yuan, B. E. Griffin, and N. R. Lemoine Virus-Associated RNA I-Deleted Adenovirus, a Potential Oncolytic Agent Targeting EBV-Associated Tumors Cancer Res., February 15, 2005; 65(4): 1523 - 1531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Glaser, J. L. Hsu, and M. L. Gulley Epstein-Barr Virus and Breast Cancer: State of the Evidence for Viral Carcinogenesis Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 688 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Thompson and R. Kurzrock Epstein-Barr Virus and Cancer Clin. Cancer Res., February 1, 2004; 10(3): 803 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Huang, H. Chen, L. Hutt-Fletcher, R. F. Ambinder, and S. D. Hayward Lytic Viral Replication as a Contributor to the Detection of Epstein-Barr Virus in Breast Cancer J. Virol., December 15, 2003; 77(24): 13267 - 13274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Speck, D. F. Callen, and R. Longnecker Absence of the Epstein-Barr Virus Genome in Breast Cancer-Derived Cell Lines J Natl Cancer Inst, August 20, 2003; 95(16): 1253 - 1254. [Full Text] [PDF]
|
|
|
|
|
|
N. Krieger, E. F. Strong, C. Makosky, and J. Weuve Breast Cancer, Birth Cohorts, and Epstein-Barr Virus: Methodological Issues in Exploring the "Hygiene Hypothesis" in Relation to Breast Cancer, Hodgkin's Disease, and Stomach Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 405 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Murray, D. Lissauer, J. Junying, G. Davies, S. Moore, A. Bell, J. Timms, D. Rowlands, C. McConkey, G. M. Reynolds, et al. Reactivity with A Monoclonal Antibody to Epstein-Barr Virus (EBV) Nuclear Antigen 1 Defines a Subset of Aggressive Breast Cancers in the Absence of the EBV Genome Cancer Res., May 1, 2003; 63(9): 2338 - 2343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Grinstein, M. V. Preciado, P. Gattuso, P. A. Chabay, W. H. Warren, E. De Matteo, and V. E. Gould Demonstration of Epstein-Barr Virus in Carcinomas of Various Sites Cancer Res., September 1, 2002; 62(17): 4876 - 4878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Chu, Y.-Y. Chen, W.-g. Chen, and L. M. Weiss No Direct Role for Epstein-Barr Virus in American Hepatocellular Carcinoma Am. J. Pathol., October 1, 2001; 159(4): 1287 - 1292. [Abstract] [Full Text]
|
|
|
|
|
|
P. G. Chu, K. L. Chang, Y.-Y. Chen, W.-G. Chen, and L. M. Weiss No Significant Association of Epstein-Barr Virus Infection with Invasive Breast Carcinoma Am. J. Pathol., August 1, 2001; 159(2): 571 - 578. [Abstract] [Full Text]
|
|
|
|
|
|
A. Rodriguez, E. J. Jung, and E. K. Flemington Cell Cycle Analysis of Epstein-Barr Virus-Infected Cells following Treatment with Lytic Cycle-Inducing Agents J. Virol., May 15, 2001; 75(10): 4482 - 4489. [Abstract] [Full Text]
|
|
|
|
|
|
A. Angeloni, A. Farina, G. Gentile, A. Capobianchi, P. Martino, V. Visco, R. Muraro, L. Frati, and A. Faggioni Epstein-Barr Virus and Breast Cancer: Search for Antibodies to the Novel BFRF1 Protein in Sera of Breast Cancer Patients J Natl Cancer Inst, April 4, 2001; 93(7): 560 - 561. [Full Text] [PDF]
|
|
|
|
|
|
S. A. McCall, J. H. Lichy, K. E. Bijwaard, N. S. Aguilera, W.-S. Chu, and J. K. Taubenberger Epstein-Barr Virus Detection in Ductal Carcinoma of the Breast J Natl Cancer Inst, January 17, 2001; 93(2): 148 - 150. [Full Text] [PDF]
|
|
|
|
|
|
P. Speck and R. Longnecker Infection of Breast Epithelial Cells With Epstein-Barr Virus Via Cell-to-Cell Contact J Natl Cancer Inst, November 15, 2000; 92(22): 1849 - 1851. [Full Text] [PDF]
|
|
|
|
|
|
M. Merchant, R. G. Caldwell, and R. Longnecker The LMP2A ITAM Is Essential for Providing B Cells with Development and Survival Signals In Vivo J. Virol., October 1, 2000; 74(19): 9115 - 9124. [Abstract] [Full Text]
|
|
|
|
|
|
S.-A. Xue, Q.-L. Lu, R. Poulsom, L. Karran, M. D. Jones, and B. E. Griffin Expression of Two Related Viral Early Genes in Epstein-Barr Virus-Associated Tumors J. Virol., March 15, 2000; 74(6): 2793 - 2803. [Abstract] [Full Text]
|
|
|
|
|
|
R. F. Ambinder Gammaherpesviruses and ""Hit-and-Run"" Oncogenesis Am. J. Pathol., January 1, 2000; 156(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
|
|
I. Magrath and K. Bhatia Breast Cancer: a New Epstein-Barr Virus-Associated Disease? J Natl Cancer Inst, August 18, 1999; 91(16): 1349 - 1350. [Full Text] [PDF]
|
|
|
|
|
|
M. Bonnet, J.-M. Guinebretiere, E. Kremmer, V. Grunewald, E. Benhamou, G. Contesso, and I. Joab Detection of Epstein-Barr Virus in Invasive Breast Cancers J Natl Cancer Inst, August 18, 1999; 91(16): 1376 - 1381. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
